US Hypersensitivity Pneumonitis Market

ID: MRFR/Pharma/18405-HCR 100 Pages Satyendra Maurya Last Updated: September 10, 2026
US Hypersensitivity Pneumonitis Market Research Report By Diagnosis Method (Blood Tests, Imaging Tests, Lung Function Tests, Biopsy, Skin Test), By Treatment Type (Corticosteroids, Immunosuppressive Agents, Antibiotics, Oxygen Therapy, Pulmonary Rehabilitation), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Urgent Care Centers) and By Cause of Hypersensitivity Pneumonitis (Organic Dust, Chemical Exposure, Animal Proteins, Mold and Fungi, Pollen) - Growth & Industry Forecast 2025 To 2035
US Hypersensitivity Pneumonitis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.71%
2024 Market Size$ 549.05 Million
2025 Market Size$ 580.4 Million
2035 Market Size$ 1,011.34 Million
Key Players
Boehringer Ingelheim
Roche
Novartis
GlaxoSmithKline
AstraZeneca
Merck & Co.
Trends
  • Rising Awareness and Diagnosis
  • Technological Advancements in Treatment
  • Regulatory Support and Research Funding
Opportunities
  • Rising Healthcare Expenditure
  • Growing Environmental Awareness
  • Advancements in Diagnostic Techniques
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Food, Beverages & Nutrition, BY Diagnosis Method (USD Million)
      1. 4.1.1 Blood Tests
      2. 4.1.2 Imaging Tests
      3. 4.1.3 Lung Function Tests
      4. 4.1.4 Biopsy
      5. 4.1.5 Skin Test
    2. 4.2 Food, Beverages & Nutrition, BY Treatment Type (USD Million)
      1. 4.2.1 Corticosteroids
      2. 4.2.2 Immunosuppressive Agents
      3. 4.2.3 Antibiotics
      4. 4.2.4 Oxygen Therapy
      5. 4.2.5 Pulmonary Rehabilitation
    3. 4.3 Food, Beverages & Nutrition, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Clinics
      3. 4.3.3 Home Care Settings
      4. 4.3.4 Research Laboratories
      5. 4.3.5 Urgent Care Centers
    4. 4.4 Food, Beverages & Nutrition, BY Cause (USD Million)
      1. 4.4.1 Organic Dust
      2. 4.4.2 Chemical Exposure
      3. 4.4.3 Animal Proteins
      4. 4.4.4 Mold and Fungi
      5. 4.4.5 Pollen
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Boehringer Ingelheim (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Novartis (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 GlaxoSmithKline (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 AstraZeneca (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Merck & Co. (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Sanofi (FR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Bristol-Myers Squibb (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Teva Pharmaceutical Industries (IL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DIAGNOSIS METHOD
    3. 6.3 US MARKET ANALYSIS BY TREATMENT TYPE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY CAUSE
    6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
    9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
    12. 6.12 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSIS METHOD, 2024 (% SHARE)
    13. 6.13 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Million)
    14. 6.14 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 (% SHARE)
    15. 6.15 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
    17. 6.17 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 FOOD, BEVERAGES & NUTRITION, BY CAUSE, 2024 (% SHARE)
    19. 6.19 FOOD, BEVERAGES & NUTRITION, BY CAUSE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DIAGNOSIS METHOD, 2025-2035 (USD Million)
      2. 7.2.2 BY TREATMENT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
      4. 7.2.4 BY CAUSE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Hypersensitivity Pneumonitis Market Segmentation

US Hypersensitivity Pneumonitis Market By Diagnosis Method (USD Million, 2025-2035)

  • Blood Tests
  • Imaging Tests
  • Lung Function Tests
  • Biopsy
  • Skin Test

US Hypersensitivity Pneumonitis Market By Treatment Type (USD Million, 2025-2035)

  • Corticosteroids
  • Immunosuppressive Agents
  • Antibiotics
  • Oxygen Therapy
  • Pulmonary Rehabilitation

US Hypersensitivity Pneumonitis Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Clinics
  • Home Care Settings
  • Research Laboratories
  • Urgent Care Centers

US Hypersensitivity Pneumonitis Market By Cause (USD Million, 2025-2035)

  • Organic Dust
  • Chemical Exposure
  • Animal Proteins
  • Mold and Fungi
  • Pollen

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.